My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

1.455 -0.085 (-5.52%)

Delayed Quote Updated: 1:48 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

34 Stocks Moving In Tuesday's Mid-Day Session ↗

June 15, 2021

Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with...

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 15, 2021

Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as...

Via Benzinga

Why Anavex Shares Are Surging Today ↗

June 14, 2021

Anavex Life Sciences Corp (NASDAQ:AVXL) shares are tr...

Via Benzinga

Why Anavex Life Sciences Stock Soared 35% Today ↗

June 14, 2021

Research published in a medical journal provides enormous hope for the company's pipeline Alzheimer's drug.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 14, 2021

Gainers RAPT Therapeutics (NASDAQ:RAPT) shares moved upwards by 111.41% to $39.26 during Monday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

June 14, 2021

Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request...

Via Benzinga

Anavex Life Sciences' Alzheimer's Candidate Mechanism Of Action Explained In Medical Journal ↗

June 14, 2021

Anavex Life Sciences Corp (NASDAQ: AVXL) has reported that ANAVEX 2-73 (blarcamesine) and ANAVEX3-71 (AF710B) are featured in a new peer-reviewed publication in...

Via Benzinga

Biotechs Ready To Roar ↗

June 13, 2021

The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...

Via Talk Markets

Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use? ↗

June 08, 2021

Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.

Via Investor's Business Daily

Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab ↗

June 07, 2021

The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.

Via Investor's Business Daily

The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks ↗

May 21, 2021

The FDA will soon review aducanumab, possibly the first new Alzheimer's treatment in years. Stakes are high for Biogen stock — and other biotech stocks too.

Via Investor's Business Daily

Anavex Life Sciences (AVXL) Q2 2021 Earnings Call Transcript ↗

May 14, 2021

AVXL earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Alzheimer's Disease: 5 Stocks on Biotech Radars ↗

April 22, 2021

What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other...

Via Talk Markets

Global Dementia Drugs Market Expected to Exceed $19.6 Billion In 2026

April 20, 2021

Via FinancialNewsMedia

Topics Death

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.